Equitable Holdings’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,379
Closed -$402K 1707
2025
Q4
$402K Sell
48,379
-33,900
-41% -$365K ﹤0.01% 1192
2025
Q3
$1.2M Buy
82,279
+21,465
+35% +$257K 0.01% 785
2025
Q2
$684K Buy
60,814
+3,500
+6% +$27.1K 0.01% 915
2025
Q1
$327K Buy
+57,314
New +$584K ﹤0.01% 1061
2024
Q3
Sell
-280
Closed -$3.74K 1268
2024
Q2
$3.74K Sell
280
-9
-3% -$269 ﹤0.01% 1210
2024
Q1
$13.4K Hold
289
﹤0.01% 1158
2023
Q4
$19.5K Hold
289
﹤0.01% 1127
2023
Q3
$20.9K Hold
289
﹤0.01% 1063
2023
Q2
$21.5K Hold
289
﹤0.01% 1035
2023
Q1
$15.4K Hold
289
﹤0.01% 972
2022
Q4
$19.5K Sell
289
-25
-8% -$2.3K ﹤0.01% 895
2022
Q3
$39K Buy
314
+9
+3% +$1.07K ﹤0.01% 859
2022
Q2
$29K Hold
305
﹤0.01% 848
2022
Q1
$49K Hold
305
﹤0.01% 864
2021
Q4
$101K Hold
305
﹤0.01% 846
2021
Q3
$141K Buy
+305
New +$148K ﹤0.01% 821

Other funds holding DNA